Larson Financial Group’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.72K Buy
67
+6
+10% +$292 ﹤0.01% 3112
2026
Q2
$3.2K Buy
61
+17
+39% +$664 ﹤0.01% 2951
2026
Q1
$1.56K Hold
44
– – ﹤0.01% 3030
2025
Q4
$1.23K Sell
44
-18
-29% -$539 ﹤0.01% 2903
2025
Q3
$1.86K Sell
62
-724
-92% -$20.4K ﹤0.01% 2740
2025
Q2
$22.5K Buy
786
+776
+7,760% +$23.1K ﹤0.01% 1436
2025
Q1
$330 Sell
10
-258
-96% -$8.41K ﹤0.01% 2675
2024
Q4
$7.71K Buy
268
+258
+2,580% +$7.42K ﹤0.01% 1561
2024
Q3
$280 Hold
10
– – ﹤0.01% 2273
2024
Q2
$241 Buy
+10
New +$245 ﹤0.01% 2015

Other funds holding ALKS

Larson Financial Group's ALKS Position: Q3 2026 in Review

Larson Financial Group increased its Alkermes (ALKS) stake by 9.8% in Q3 2026, buying an estimated $292 and bringing the position to 67 shares worth $2.72K. The position accounts for ﹤0.01% of the portfolio, ranked #3112.

Larson Financial Group first reported a position in ALKS in Q2 2024 and has held it in 10 quarters since. The position peaked at $22.5K in Q2 2025. 415 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

  • Larson Financial Group held 67 shares of Alkermes worth $2.72K as of Q3 2026.
  • Larson Financial Group bought 6 Alkermes shares in Q3 2026, an estimated $292.
  • Alkermes made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3112 holding.
  • Larson Financial Group first reported a position in Alkermes in Q2 2024 and has held it in 10 quarters since.
  • Larson Financial Group's Alkermes position peaked at $22.5K in Q2 2025.
  • 415 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.